DIA
XENT

Denver Investment Advisors’s Intersect ENT, Inc XENT Stock Holding History

Denver Investment Advisors’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$573K Buy
14,570
+466
+3% +$17K 0.03% 300
2017
Q4 		$457K Sell
14,104
-531
-4% -$15.9K 0.02% 330
2017
Q3 		$456K Sell
14,635
-6,270
-30% -$186K 0.02% 333
2017
Q2 		$584K Sell
20,905
-9,125
-30% -$207K 0.03% 295
2017
Q1 		$515K Sell
30,030
-1,410
-4% -$19.8K 0.02% 325
2016
Q4 		$380K Buy
+31,440
New +$407K 0.02% 388

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Denver Investment Advisors's XENT Position: Q1 2018 in Review

Denver Investment Advisors increased its Intersect ENT, Inc (XENT) stake by 3.3% in Q1 2018, buying an estimated $17K and bringing the position to 14,570 shares worth $573K. The position accounts for 0.03% of the portfolio, ranked #300.

Denver Investment Advisors first reported a position in XENT in Q4 2016 and has held it in 6 quarters since. The position peaked at $584K in Q2 2017. 172 funds tracked by Wall St. Rank hold XENT as of Q1 2018.

  • Denver Investment Advisors held 14,570 shares of Intersect ENT, Inc worth $573K as of Q1 2018.
  • Denver Investment Advisors bought 466 Intersect ENT, Inc shares in Q1 2018, an estimated $17K.
  • Intersect ENT, Inc made up 0.03% of Denver Investment Advisors's portfolio in Q1 2018, its #300 holding.
  • Denver Investment Advisors first reported a position in Intersect ENT, Inc in Q4 2016 and has held it in 6 quarters since.
  • Denver Investment Advisors's Intersect ENT, Inc position peaked at $584K in Q2 2017.
  • 172 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2018.

Based on Denver Investment Advisors's 13F filing for Q1 2018, filed 10 May 2018.